Agios Pharma (AGIO)
NASDAQ:AGIO
Holding AGIO?
Track your performance easily

Agios Pharma (AGIO) Financial Statements

588 Followers

Agios Pharma Financial Overview

Agios Pharma's market cap is currently ―. The company's EPS TTM is $11.367; its P/E ratio is 3.94; Agios Pharma is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-1.67. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 8.96M$ 8.62M$ 8.19M$ 7.10M$ 7.40M
Gross Profit$ 8.18M$ 7.12M$ 7.56M$ 6.52M$ 6.77M
EBIT$ -102.81M$ -96.12M$ -81.55M$ -106.28M$ -91.32M
EBITDA$ -101.47M$ -89.14M$ -79.92M$ -104.87M$ -85.92M
Net Income Common Stockholders$ 947.91M$ -96.12M$ -81.55M$ -95.94M$ -91.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.00B$ 569.89M$ 597.99M$ 776.93M$ 647.49M
Total Assets$ 1.79B$ 773.06M$ 849.71M$ 937.12M$ 1.01B
Total Debt$ 60.83M$ 64.62M$ 68.35M$ 72.00M$ 75.50M
Net Debt$ -943.92M$ -505.27M$ -529.64M$ -704.93M$ -571.99M
Total Liabilities$ 165.12M$ 112.55M$ 105.79M$ 126.10M$ 120.42M
Stockholders Equity$ 1.63B$ 660.51M$ 743.92M$ 811.02M$ 886.84M
Cash Flow-
Free Cash Flow$ -84.64M$ -72.75M$ -99.97M$ -72.72M$ -60.84M
Operating Cash Flow$ -84.22M$ -72.59M$ -99.87M$ -72.49M$ -61.64M
Investing Cash Flow$ 250.79M$ 37.24M$ 124.56M$ 95.51M$ 39.34M
Financing Cash Flow$ 2.64M$ 1.10M$ 5.86M$ 847.00K$ 1.88M
Currency in USD

Agios Pharma Earnings and Revenue History

Agios Pharma Debt to Assets

Agios Pharma Cash Flow

Agios Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis